Nasal Dorsum Augmentation with Botulinum Toxin A: A Pilot Study.

Nuntida Salakshna, Wilai Thanasarnaksorn, Thanan Supasiri

Open access · greenAbstract read

In one paragraph

Article in The Journal of clinical and aesthetic dermatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.1field-weighted citation impact, top 49% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

The Use of Botulinum Toxin for Nasal Esthetics: A Systematic Review.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2024
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Nuntida SalakshnaDr. Thanasarnaksorn is with the Samitivej Esthetics Institute, Samitivej Sukhumvit Hospital, and the Division of Dermatology, Department of Medicine, Faculty of Medicine at Ramathibodi Hospital of Mahidol University in Bangkok, Thailand.

Wilai ThanasarnaksornDr. Thanasarnaksorn is with the Samitivej Esthetics Institute, Samitivej Sukhumvit Hospital, and the Division of Dermatology, Department of Medicine, Faculty of Medicine at Ramathibodi Hospital of Mahidol University in Bangkok, Thailand.

Thanan SupasiriDr. Thanasarnaksorn is with the Samitivej Esthetics Institute, Samitivej Sukhumvit Hospital, and the Division of Dermatology, Department of Medicine, Faculty of Medicine at Ramathibodi Hospital of Mahidol University in Bangkok, Thailand.

Chulalongkorn University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBotulinum toxin type A (BTxA) is used for cosmetic procedures, but its use for nasal dorsum augmentation has, to our knowledge, never been studied.

objectiveHere, we describe a method for using BTxA injection for nasal dorsum augmentation.

methodsThis was a pilot study. Participants aged 20 to 60 years were recruited and injected with BTxA in the upper nasal area with either Xeomin

resultsFourteen participants, including two men and 12 women, aged 35.78±9.16 years were recruited. Overall, the volume of the upper nasal area increased after BTxA injection (

conclusionThis study suggests that injecting BTxA in the upper nasal area is a convenient, minimally invasive technique with minimal side effects for nasal dorsum augmentation.

Indexed as

botulinum toxininjectionNasal dorsum augmentation

Identifiers

PMID34840660

PMCPMC8570657

OpenAlexW3215017759

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.